Piramal Pharma Limited has made a notable stride in sustainability by converting its coal-fired steam boiler at the Digwal facility in India to operate on biomass briquettes, a renewable energy source. This transition is expected to prevent approximately 24,000 tons of CO2 equivalent emissions annually,aligning with the company’s goal to reduce greenhouse gas emissions by 42% by 2030. Nandini Piramal, Chairperson of Piramal Pharma, emphasized the company’s commitment to minimizing its ecological footprint while promoting sustainable production practices. The use of biomass briquettes, made from agricultural waste, not only supports circular economy principles but also sets a new industry standard for environmentally responsible pharmaceutical manufacturing. this initiative underscores Piramal’s dedication to achieving global sustainability targets while maintaining operational excellence.
Q&A with Nandini Piramal: Driving Sustainability in Pharmaceutical Manufacturing
Time.news Editor: Nandini, it’s exciting to see Piramal Pharma Limited make such significant strides in sustainability by transitioning to biomass briquettes at your Digwal facility. Can you elaborate on the importance of this shift in the context of global sustainability targets?
Nandini Piramal: Absolutely! The transition from coal-fired steam boilers to biomass briquettes is a critical step for us. By operating on this renewable energy source, we anticipate preventing approximately 24,000 tons of CO2 equivalent emissions annually. This aligns seamlessly with our commitment to reducing greenhouse gas emissions by 42% by 2030. It’s not just about meeting targets; it’s about taking responsible actions that positively impact the environment.
time.news Editor: That’s a substantial reduction in emissions. How does this initiative reflect Piramal’s commitment to minimizing its ecological footprint?
Nandini Piramal: Our commitment to sustainability is woven into the fabric of our operations. By using biomass briquettes made from agricultural waste, we are not merely reducing our carbon footprint; we are also supporting reusability and circular economy principles. This initiative not only enhances our environmental performance but sets a new industry standard for environmentally responsible pharmaceutical manufacturing.
time.news Editor: Interesting point about the circular economy! How do you see this initiative influencing the pharmaceutical manufacturing industry as a whole?
Nandini Piramal: We believe that our shift will inspire other companies in the pharmaceutical industry to adopt similar lasting practices. As climate change becomes increasingly urgent,the demand for eco-pleasant operations will grow,creating pressure for companies to innovate. Dragging one’s feet in this area will only lead to greater complications in recovering from environmental damage.
Time.news Editor: It’s clear that your company takes this issue seriously. Can you share any practical advice for other companies looking to undertake similar sustainability initiatives?
Nandini Piramal: Certainly! First, companies should start by assessing their current energy consumption and identifying the highest sources of emissions.Then, they should research renewable energy alternatives applicable to their operations. Collaboration is key; engage with suppliers, industry peers, and sustainability consultants for insights and strategies that have proven triumphant. Lastly, always communicate progress transparently to stakeholders, as that builds credibility and inspires further innovation.
Time.news Editor: Thank you, Nandini, for sharing your insights. It’s inspiring to see how Piramal Pharma is leading the way in sustainable practices within the pharmaceutical sector.
Nandini Piramal: Thank you for the opportunity to discuss our initiatives. Together, we can pave the way for a more sustainable future in our industry.